EDGAR Filing Documents for 0001104659-23-041133

Form 8-K - Current report:

SEC Accession No. 0001104659-23-041133

Filing Date

2023-04-04

Accepted

2023-04-04 06:05:27

Documents

Period of Report

2023-03-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2311160d1_8k.htm iXBRL	8-K	34583
2	EXHIBIT 4.1	tm2311160d1_ex4-1.htm	EX-4.1	113158
3	EXHIBIT 4.2	tm2311160d1_ex4-2.htm	EX-4.2	110871
4	EXHIBIT 5.1	tm2311160d1_ex5-1.htm	EX-5.1	17379
5	EXHIBIT 10.1	tm2311160d1_ex10-1.htm	EX-10.1	236847
6	EXHIBIT 99.1	tm2311160d1_ex99-1.htm	EX-99.1	20483
10	GRAPHIC	tm2311160d1_ex99-1img01.jpg	GRAPHIC	7396
11	GRAPHIC	tm2311160d1_ex5-1img01.jpg	GRAPHIC	5846
	Complete submission text file	0001104659-23-041133.txt		855792

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	ckpt-20230330.xsd	EX-101.SCH	3045
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ckpt-20230330_lab.xml	EX-101.LAB	34476
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ckpt-20230330_pre.xml	EX-101.PRE	22603
13	EXTRACTED XBRL INSTANCE DOCUMENT	tm2311160d1_8k_htm.xml	XML	3721

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453

Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500

Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)